Paper of the Month - June, 2012

0 rating

A randomized double-blind placebocontrolled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.

Blume-Peytavi U, Lönnfors S, Hillmann K et al.
The current article details the results from a double-blind, randomized, placebo controlled pilot study involving 16 healthy male volunteers aged 23–35 years with recently developed frontotemporal alopecia (Hamilton stage II–III).


WEB LINKS

SUBMIT AN ARTICLE